Trimebutine

Trimebutine
Clinical data
Trade namesDebridat, Recutin, Polybutin, others
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Oral
Drug classVarious actions
ATC code
Pharmacokinetic data
Metabolitesnortrimebutine, N-didesmethyltrimebutine, 2-dimethylamino-2-phenylbutan-1-ol, 2-methylamino-2-phenylbutan-1-ol, 2-amino-2-phenylbutan-1-ol
Elimination half-life2.77 h (for oral dose 200 mg)
Excretionrenal, fecal
Identifiers
  • 2-(dimethylamino)-2-phenylbutyl 3,4,5-trimethoxybenzoate
CAS Number
PubChem CID
PubChem SID
ChemSpider
UNII
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.049.354
Chemical and physical data
FormulaC22H29NO5
Molar mass387.476 g·mol−1
3D model (JSmol)
Density1.1 ± 0.1 g/cm3 g/cm3
Boiling point457.9 °C (856.2 °F) at 760 mmHg
  • CCC(COC(=O)C1=CC(=C(C(=C1)OC)OC)OC)(C2=CC=CC=C2)N(C)C
  • InChI=1S/C22H29NO5/c1-7-22(23(2)3,17-11-9-8-10-12-17)15-28-21(24)16-13-18(25-4)20(27-6)19(14-16)26-5/h8-14H,7,15H2,1-6H3 X markN
  • Key:LORDFXWUHHSAQU-UHFFFAOYSA-N X markN
 X markNcheckY (what is this?)  (verify)

Trimebutine is a drug which is used in the treatment of irritable bowel syndrome and other gastrointestinal disorders. It is sometimes combined with simethicone as a combination drug. Trimebutine is formulated as a tablet or granules for oral suspension.